Healthcare -
Biotechnology - NASDAQ - US
$ 21.47
-2.36 %
$ 1.05 B
Market Cap
-11.36
P/E
ELVN - CASH & EQUIVALENTS
Cash & Equivalents ELVN - Enliven Therapeutics, Inc.
100 M
LAST VALUE
-4.60%
2 YEAR CAGR
68.46%
5 YEAR CAGR
0.00%
10 YEAR CAGR